Henry Schein, Inc. (NASDAQ:HSIC) Shares Purchased by Quent Capital LLC

Quent Capital LLC raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 91.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 677 shares of the company’s stock after buying an additional 323 shares during the quarter. Quent Capital LLC’s holdings in Henry Schein were worth $47,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Equitable Trust Co. acquired a new stake in Henry Schein during the fourth quarter valued at approximately $417,000. Wingate Wealth Advisors Inc. acquired a new stake in shares of Henry Schein during the 4th quarter worth approximately $176,000. Savant Capital LLC raised its position in shares of Henry Schein by 43.9% during the 4th quarter. Savant Capital LLC now owns 4,651 shares of the company’s stock worth $322,000 after purchasing an additional 1,420 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Henry Schein by 3.8% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,491 shares of the company’s stock worth $934,000 after purchasing an additional 497 shares during the period. Finally, GHP Investment Advisors Inc. raised its position in shares of Henry Schein by 2.2% during the 4th quarter. GHP Investment Advisors Inc. now owns 55,739 shares of the company’s stock worth $3,857,000 after purchasing an additional 1,176 shares during the period. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on HSIC shares. Mizuho started coverage on Henry Schein in a research report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Jefferies Financial Group increased their price target on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Bank of America upgraded Henry Schein from an “underperform” rating to a “buy” rating and increased their price target for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Barrington Research increased their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $80.10.

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $77.62 on Friday. The stock has a fifty day moving average price of $73.85 and a two-hundred day moving average price of $71.93. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market cap of $9.68 billion, a P/E ratio of 31.94, a PEG ratio of 2.21 and a beta of 0.91. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63.

Insider Buying and Selling at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.